Consistent beneficial effect with GLP-1RA across broad range of kidney function and kidney damage
This video was recorded during the EASD annual meeting 2022 in Stockholm, Sweden.
Prof. Peter Rossing is head of research and chief physician at the Steno Diabetes Center in Copenhagen, Denmark.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.